TGFB1 and Hepatic fibrosis: They found that by using these nanoparticles to target the TGF-β/Smad and NF-κB pathways, they were able to effectively both stage liver fibrosis as well as treat it by degrading collagen and modulating immune responses in their mouse model [179].